These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24983463)

  • 1. Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients.
    Chen J; Shao J; Cai R; Shen Y; Zhang R; Liu L; Qi T; Lu H
    PLoS One; 2014; 9(7):e100446. PubMed ID: 24983463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy.
    Chen J; Xun J; Yang J; Ji Y; Liu L; Qi T; Wang Z; Zhang R; Shen Y; Ponte R; Mehraj V; Routy JP; Lu H
    Clin Infect Dis; 2019 Apr; 68(8):1274-1281. PubMed ID: 30107503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.
    Lee SA; Mefford JA; Huang Y; Witte JS; Martin JN; Haas DW; Mclaren PJ; Mushiroda T; Kubo M; Byakwaga H; Hunt PW; Kroetz DL
    AIDS; 2016 Jul; 30(11):1807-15. PubMed ID: 27088321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.
    Byakwaga H; Boum Y; Huang Y; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Cao H; Haberer JE; Deeks SG; Bangsberg DR; McCune JM; Martin JN; Hunt PW
    J Infect Dis; 2014 Aug; 210(3):383-91. PubMed ID: 24585899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan-Kynurenine Pathway Activation and Cognition in Virally Suppressed Women With HIV.
    Shorer EF; Dastgheyb RM; French AL; Daubert E; Morack R; Yohannes T; Clish C; Gustafson D; Sharma A; Rogando A; Qi Q; Burgess H; Rubin LH; Weber KM
    J Acquir Immune Defic Syndr; 2024 Aug; 96(5):494-500. PubMed ID: 38985447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up.
    Gaardbo JC; Trøsied M; Stiksrud B; Midttun Ø; Ueland PM; Ullum H; Nielsen SD
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):228-35. PubMed ID: 26470032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia.
    Wang CY; Shi Y; Min YN; Zhu XJ; Guo CS; Peng J; Dong XY; Qin P; Sun JZ; Hou M
    J Clin Immunol; 2011 Aug; 31(4):643-9. PubMed ID: 21487895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
    Schefold JC; Zeden JP; Pschowski R; Hammoud B; Fotopoulou C; Hasper D; Fusch G; Von Haehling S; Volk HD; Meisel C; Schütt C; Reinke P
    Scand J Infect Dis; 2010 Mar; 42(3):164-71. PubMed ID: 19958238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
    Zangerle R; Widner B; Quirchmair G; Neurauter G; Sarcletti M; Fuchs D
    Clin Immunol; 2002 Sep; 104(3):242-7. PubMed ID: 12217334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa.
    Byakwaga H; Hunt PW; Laker-Oketta M; Glidden DV; Huang Y; Bwana BM; Mocello AR; Bennett J; Walusansa V; Dollard SC; Bangsberg DR; Mbidde EK; Martin JN
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):296-303. PubMed ID: 26181812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
    Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
    Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
    Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
    Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
    Neurauter G; Zangerle R; Widner B; Quirchmair G; Sarcletti M; Fuchs D
    Adv Exp Med Biol; 2003; 527():317-23. PubMed ID: 15206745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
    Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
    J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
    Favre D; Mold J; Hunt PW; Kanwar B; Loke P; Seu L; Barbour JD; Lowe MM; Jayawardene A; Aweeka F; Huang Y; Douek DC; Brenchley JM; Martin JN; Hecht FM; Deeks SG; McCune JM
    Sci Transl Med; 2010 May; 2(32):32ra36. PubMed ID: 20484731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans.
    Martinez P; Tsai AC; Muzoora C; Kembabazi A; Weiser SD; Huang Y; Haberer JE; Martin JN; Bangsberg DR; Hunt PW
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):456-62. PubMed ID: 24220289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
    Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
    Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia.
    Suzuki Y; Suda T; Yokomura K; Suzuki M; Fujie M; Furuhashi K; Hahimoto D; Enomto N; Fujisawa T; Nakamura Y; Inui N; Nakano Y; Nakamura H; Chida K
    J Infect; 2011 Sep; 63(3):215-22. PubMed ID: 21784100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux?
    Adu-Gyamfi CG; Savulescu D; George JA; Suchard MS
    Front Cell Infect Microbiol; 2019; 9():372. PubMed ID: 31737575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.